Navigation Links
Zimmer Introduces Comprehensive Range of Trabecular Metal™ Augment Shapes and Cones for Knee Revision Surgery
Date:5/17/2011

WARSAW, Ind., May 17, 2011 /PRNewswire/ --Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced the launch of a new, comprehensive range of Trabecular Metal Material augment shapes and cones for use in knee revision surgeries.  

During revision surgeries, surgeons are often faced with a range of small to large cavitary bone defects.  The new augments are designed to fill these defects, provide a structural foundation to the existing bone and help support revision knee implants.

Trabecular Metal Tibial and Femoral Cone Augments have the potential to provide reliable structural replacement of bone and stable fixation for femoral and tibial articulating components in even the most challenging knee revision cases.  Designed to treat deficiencies in the knee independent of the final implant position, the tapered shape of the augments fits the patient's anatomy without dictating implant alignment.  The new augments are designed for use with the NexGen® Knee System.

"The launch of this fully-instrumented range of revision knee cones reinforces Zimmer's commitment to providing surgeons with the most comprehensive array of solutions to confidently approach knee revisions with the NexGen Knee System," said Jeffery A. McCaulley, President, Zimmer Reconstructive.  "The broad range of anatomic sizing options now available allows surgeons to more accurately position implants and fill defects in all kinds of knee revision cases."

The augments are constructed from Zimmer's Trabecular Metal material, a highly porous biomaterial that resembles the structure, function and physiology of trabecular bone.  No other porous metal material is supported by the amount of peer-reviewed, published clinical data of Trabecular Metal Technology and its history of clinical success in orthopaedic applications.  This novel material supports bone formation, enabling biologic fixation and a stiffness similar to cancellous bone.  The elasticity of Trabecular Metal Technology provides more normal physiological loading which has the potential to decrease stress shielding and improve long-term implant fixation.

For more information, visit www.zimmer.com.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2010 sales were approximately $4.2 billion.  The Company is supported by the efforts of more than 8,000 employees worldwide.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
3. Zimmer Reports Fourth Quarter and 2009 Financial Results
4. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2009 Results
6. Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference
7. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
8. Zimmer Holdings to Present at Cowen & Company 30th Annual Health Care Conference
9. Zimmer Natural Knee Celebrates 25 Years of Excellence
10. Zimmer Holdings to Present at Bank of America Merrill Lynch 2010 Health Care Conference
11. Zimmer Holdings to Present at Bairds 2010 Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016  Compass Diversified Holdings (NYSE: ... owner of leading middle market businesses, announced today its ... 31, 2016. First Quarter 2016 Highlights ... ("CAD" or "Cash Flow") of $13.6 million for the ... of $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... Yissum Research Development Company ... that it had signed an exclusive world-wide licensing and ... novel protein degradation and immunomodulatory drugs for cancer and ... candidates representing first-in-class therapy for hematologic and solid malignancies. ... The novel technology was developed by Yinon ...
(Date:5/4/2016)... 2016 Research and ... Acute Myeloid Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia ...
Breaking Medicine Technology:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... Multiple award ... been family-owned and operated for over 35 years. Maintaining core values of exceptional customer ... their success and made them a leading name in San Diego plumbing, and other ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor ... education and corporate training, and the National Military Family Association, a nonprofit that ... as the second full-tuition scholarship recipient of 2016. , “Being awarded this ...
(Date:5/6/2016)... ... 2016 , ... “ Crossing Over: Affirmations of Faith in the Midst of ... allowed those holding vigil to glimpse into the supernatural as their lives ended. With ... spiritually and practically gain insight into providing care to terminal patients. , “I ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and profession ... the impact our aging population has on communities and resources. Aging Life Care plays ... and face age-related challenges. , Aging Life Care is a holistic, client-centered approach ...
(Date:5/5/2016)... ... May 05, 2016 , ... Textile Exchange is excited ... for public stakeholder review. The stakeholder review is an important opportunity for interested parties ... and delivers value to the wool industry., The RWS is intended to be a ...
Breaking Medicine News(10 mins):